• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.23% Nasdaq Down0.63%

    Valeant Pharmaceuticals International, Inc. (VRX)

    -NYSE
    202.02 Down 8.40(3.99%) 4:01PM EDT
    |After Hours : 203.84 Up 1.82 (0.90%) 5:28PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 8,263,500   5,769,600   3,480,400  
    Cost of Revenue2,254,600  1,905,100  969,700  
    Gross Profit 6,008,900   3,864,500   2,510,700  
    Operating Expenses
    Research Development246,000  156,800  79,100  
    Selling General and Administrative1,743,500  1,563,200  887,400  
    Non Recurring429,000  652,000  535,600  
    Others1,550,700  1,902,000  928,900  
    Total Operating Expenses3,969,200  4,274,000  2,431,000  
    Operating Income or Loss 2,039,700   (409,500) 79,700  
    Income from Continuing Operations
    Total Other Income/Expenses Net23,900  (60,600)7,700  
    Earnings Before Interest And Taxes2,063,600  (470,100)87,400  
    Interest Expense971,000  844,300  481,600  
    Income Before Tax1,092,600  (1,314,400)(394,200)
    Income Tax Expense180,400  (450,800)(278,200)
    Minority Interest1,300  (2,500) -  
    Net Income From Continuing Ops783,900  (931,100)(136,100)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 913,500   (866,100) (116,000)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 913,500   (866,100) (116,000)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.